The human body is a holistic system, its biology is multi-faceted and intricately interconnected. Traditional drug discovery and development efforts have relied on simplified models and reductionistic tools to discover and test new drugs. Now it's time to make a change. Xellar is a Wet-AI, Artificial Intelligence and machine learning combined with large-scale wet-lab experiments, biotech company tackling the most challenging problem in modern drug discovery – harnessing the complexity of human biology to accelerate drug discovery and development.
| Website | http://www.xellarbio.com |
| Employees | 30 (23 on RocketReach) |
| Founded | 2022 |
| Address | 500 Rutherford Ave, Boston, Massachusetts 02129, US |
| Industry | Biotechnology Research |
| Keywords | Biotechnology, Drug Discovery, Pharmaceutical Research, Precision Medicine, Systems Biology, Holistic Health, Biomedical Research, Therapeutics, Drug Development, Life Sciences, Biopharma, Clinical Trials, Health Technology, Molecular Biology, Bioinformatics, Cell Biology, Genomics, Proteomics, Biomarkers, Drug Delivery |
| Competitors | Thermo Fisher Scientific, Illumina, Agilent Technologies, PerkinElmer, Inc., GE HealthCare, Bio-Rad Laboratories, Roche, Merck Group, Novartis, Amgen +44 more (view full list) |
Looking for a particular Xellar Biosystems employee's phone or email?
Xin Xie is the Co-Founder and CEO of Xellar Biosystems.
23 people are employed at Xellar Biosystems.
Xellar Biosystems is based in Boston, Massachusetts.